Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Blood Vessel Prosthesis Implantation | 94 | 2024 | 1425 | 12.170 |
Why?
|
Endovascular Procedures | 95 | 2024 | 2181 | 9.930 |
Why?
|
Aortic Aneurysm, Thoracic | 57 | 2024 | 695 | 9.000 |
Why?
|
Aortic Aneurysm, Abdominal | 63 | 2024 | 1228 | 8.410 |
Why?
|
Blood Vessel Prosthesis | 66 | 2024 | 951 | 8.040 |
Why?
|
Prosthesis Design | 54 | 2024 | 2114 | 3.580 |
Why?
|
Stents | 45 | 2024 | 3177 | 3.450 |
Why?
|
Aortic Aneurysm | 19 | 2024 | 648 | 2.880 |
Why?
|
Spinal Cord Ischemia | 11 | 2024 | 94 | 2.770 |
Why?
|
Vascular Surgical Procedures | 22 | 2024 | 1489 | 2.490 |
Why?
|
Iliac Aneurysm | 8 | 2024 | 37 | 2.320 |
Why?
|
Aortic Diseases | 12 | 2022 | 735 | 1.780 |
Why?
|
Endoleak | 19 | 2024 | 111 | 1.730 |
Why?
|
Aortography | 31 | 2024 | 421 | 1.670 |
Why?
|
Iliac Artery | 11 | 2024 | 343 | 1.660 |
Why?
|
Aortic Rupture | 9 | 2024 | 319 | 1.640 |
Why?
|
Aorta, Thoracic | 10 | 2021 | 1096 | 1.450 |
Why?
|
Vascular Patency | 18 | 2024 | 911 | 1.420 |
Why?
|
Ohio | 22 | 2020 | 322 | 1.340 |
Why?
|
Aorta, Abdominal | 7 | 2023 | 625 | 1.230 |
Why?
|
Endarterectomy, Carotid | 10 | 2024 | 554 | 1.210 |
Why?
|
Postoperative Complications | 49 | 2024 | 15637 | 1.090 |
Why?
|
Treatment Outcome | 110 | 2024 | 64681 | 1.080 |
Why?
|
Time Factors | 81 | 2024 | 39957 | 1.060 |
Why?
|
Aneurysm | 7 | 2023 | 337 | 1.050 |
Why?
|
Renal Artery | 5 | 2024 | 351 | 0.970 |
Why?
|
Subclavian Artery | 4 | 2021 | 133 | 0.960 |
Why?
|
Arterial Occlusive Diseases | 11 | 2020 | 749 | 0.930 |
Why?
|
Angioplasty, Balloon | 6 | 2020 | 589 | 0.910 |
Why?
|
Risk Factors | 97 | 2024 | 74239 | 0.870 |
Why?
|
Graft Occlusion, Vascular | 8 | 2021 | 537 | 0.760 |
Why?
|
Risk Assessment | 49 | 2024 | 24021 | 0.700 |
Why?
|
Aged, 80 and over | 65 | 2024 | 58952 | 0.680 |
Why?
|
Peripheral Vascular Diseases | 5 | 2023 | 488 | 0.680 |
Why?
|
Databases, Factual | 21 | 2024 | 7966 | 0.670 |
Why?
|
Device Removal | 4 | 2018 | 629 | 0.650 |
Why?
|
Matrix Metalloproteinase 9 | 8 | 2012 | 631 | 0.640 |
Why?
|
Retrospective Studies | 81 | 2024 | 80674 | 0.640 |
Why?
|
Aged | 109 | 2024 | 169288 | 0.610 |
Why?
|
Angiotensin II | 3 | 2012 | 848 | 0.600 |
Why?
|
Congresses as Topic | 2 | 2020 | 803 | 0.600 |
Why?
|
Ehlers-Danlos Syndrome | 2 | 2016 | 93 | 0.600 |
Why?
|
Biomedical Research | 4 | 2022 | 3434 | 0.580 |
Why?
|
Carotid Stenosis | 7 | 2024 | 859 | 0.570 |
Why?
|
Vascular Diseases | 4 | 2022 | 1160 | 0.560 |
Why?
|
Prosthesis Failure | 8 | 2015 | 1204 | 0.540 |
Why?
|
Hypoalbuminemia | 1 | 2017 | 86 | 0.530 |
Why?
|
Reoperation | 18 | 2020 | 4303 | 0.510 |
Why?
|
Kaplan-Meier Estimate | 16 | 2017 | 6486 | 0.510 |
Why?
|
Retreatment | 6 | 2021 | 598 | 0.500 |
Why?
|
Aorta | 11 | 2023 | 2040 | 0.490 |
Why?
|
Humans | 180 | 2024 | 761208 | 0.490 |
Why?
|
Male | 129 | 2024 | 360693 | 0.460 |
Why?
|
Pelvis | 2 | 2017 | 735 | 0.430 |
Why?
|
Chi-Square Distribution | 12 | 2016 | 3418 | 0.420 |
Why?
|
Matrix Metalloproteinase 2 | 5 | 2012 | 459 | 0.420 |
Why?
|
Female | 119 | 2024 | 392544 | 0.410 |
Why?
|
Forecasting | 1 | 2021 | 2928 | 0.400 |
Why?
|
STAT1 Transcription Factor | 2 | 2011 | 340 | 0.400 |
Why?
|
Interleukin-5 | 1 | 2012 | 266 | 0.380 |
Why?
|
Femoral Artery | 3 | 2020 | 826 | 0.370 |
Why?
|
Apolipoproteins E | 3 | 2012 | 1443 | 0.370 |
Why?
|
Urinary Retention | 2 | 2023 | 106 | 0.360 |
Why?
|
STAT Transcription Factors | 1 | 2011 | 188 | 0.360 |
Why?
|
Education, Medical, Graduate | 3 | 2024 | 2374 | 0.350 |
Why?
|
Physicians, Women | 3 | 2022 | 510 | 0.350 |
Why?
|
Middle Aged | 77 | 2024 | 220853 | 0.340 |
Why?
|
Viscera | 1 | 2010 | 138 | 0.330 |
Why?
|
Ischemia | 4 | 2018 | 1889 | 0.320 |
Why?
|
Vascular Grafting | 3 | 2020 | 162 | 0.320 |
Why?
|
Lower Extremity | 5 | 2022 | 1201 | 0.320 |
Why?
|
Pancreatic Elastase | 4 | 2005 | 126 | 0.300 |
Why?
|
Laparotomy | 2 | 2020 | 456 | 0.300 |
Why?
|
Tomography, X-Ray Computed | 32 | 2024 | 20588 | 0.300 |
Why?
|
Platelet Aggregation Inhibitors | 3 | 2024 | 2746 | 0.290 |
Why?
|
Peripheral Arterial Disease | 4 | 2024 | 1275 | 0.290 |
Why?
|
Hematoma | 4 | 2022 | 763 | 0.290 |
Why?
|
Artificial Intelligence | 1 | 2022 | 2576 | 0.290 |
Why?
|
Decision Support Techniques | 1 | 2017 | 2004 | 0.280 |
Why?
|
Prospective Studies | 25 | 2024 | 54435 | 0.280 |
Why?
|
Societies, Medical | 2 | 2020 | 3923 | 0.280 |
Why?
|
Cardiology | 1 | 2018 | 1693 | 0.280 |
Why?
|
Vascular Malformations | 1 | 2012 | 468 | 0.270 |
Why?
|
Thrombosis | 7 | 2024 | 2944 | 0.270 |
Why?
|
Matrix Metalloproteinase 14 | 1 | 2006 | 60 | 0.270 |
Why?
|
Aortic Valve Insufficiency | 1 | 2010 | 576 | 0.260 |
Why?
|
Inguinal Canal | 1 | 2006 | 71 | 0.260 |
Why?
|
Coronary Artery Bypass | 3 | 2019 | 2193 | 0.260 |
Why?
|
Coronavirus Infections | 2 | 2020 | 3093 | 0.260 |
Why?
|
Pneumonia, Viral | 2 | 2020 | 3215 | 0.250 |
Why?
|
Aneurysm, False | 2 | 2017 | 255 | 0.240 |
Why?
|
Calcium Channel Blockers | 1 | 2008 | 691 | 0.240 |
Why?
|
Gene Expression Regulation, Enzymologic | 2 | 2006 | 1168 | 0.240 |
Why?
|
Fluoroscopy | 3 | 2022 | 947 | 0.230 |
Why?
|
Ileus | 1 | 2024 | 66 | 0.230 |
Why?
|
Pandemics | 3 | 2020 | 8663 | 0.230 |
Why?
|
Alloys | 1 | 2024 | 110 | 0.230 |
Why?
|
Peptidyl-Dipeptidase A | 1 | 2005 | 328 | 0.230 |
Why?
|
Venous Thrombosis | 3 | 2020 | 1304 | 0.220 |
Why?
|
Inflammation Mediators | 1 | 2012 | 1885 | 0.220 |
Why?
|
Marfan Syndrome | 2 | 2023 | 236 | 0.220 |
Why?
|
Loeys-Dietz Syndrome | 1 | 2023 | 40 | 0.220 |
Why?
|
omega-N-Methylarginine | 2 | 2002 | 108 | 0.220 |
Why?
|
Feasibility Studies | 5 | 2024 | 5250 | 0.210 |
Why?
|
Spinal Cord Injuries | 2 | 2023 | 924 | 0.210 |
Why?
|
Splenic Artery | 1 | 2023 | 58 | 0.210 |
Why?
|
Molecular Diagnostic Techniques | 1 | 2007 | 610 | 0.200 |
Why?
|
Thrombelastography | 1 | 2024 | 187 | 0.200 |
Why?
|
Treatment Failure | 6 | 2020 | 2643 | 0.190 |
Why?
|
United States | 29 | 2024 | 72339 | 0.190 |
Why?
|
Popliteal Artery | 3 | 2008 | 310 | 0.190 |
Why?
|
Predictive Value of Tests | 7 | 2024 | 15308 | 0.190 |
Why?
|
Patient Selection | 6 | 2024 | 4246 | 0.190 |
Why?
|
Anticoagulants | 4 | 2024 | 4795 | 0.190 |
Why?
|
Angiotensin-Converting Enzyme Inhibitors | 1 | 2008 | 1504 | 0.190 |
Why?
|
Stroke | 7 | 2024 | 9721 | 0.190 |
Why?
|
Renin-Angiotensin System | 1 | 2005 | 735 | 0.180 |
Why?
|
Cardiovascular Agents | 1 | 2007 | 842 | 0.180 |
Why?
|
Radiographic Image Interpretation, Computer-Assisted | 3 | 2017 | 1221 | 0.180 |
Why?
|
Mesenteric Veins | 1 | 2021 | 86 | 0.180 |
Why?
|
Ischemic Attack, Transient | 2 | 2024 | 874 | 0.180 |
Why?
|
Aortic Valve | 1 | 2010 | 1959 | 0.180 |
Why?
|
Sex Factors | 8 | 2024 | 10553 | 0.180 |
Why?
|
Thrombolytic Therapy | 3 | 2024 | 2055 | 0.180 |
Why?
|
Arteritis | 1 | 2002 | 158 | 0.180 |
Why?
|
Journal Impact Factor | 1 | 2022 | 153 | 0.180 |
Why?
|
Connective Tissue Diseases | 1 | 2023 | 285 | 0.170 |
Why?
|
Tunica Intima | 1 | 2002 | 458 | 0.170 |
Why?
|
Diverticulum | 1 | 2021 | 137 | 0.170 |
Why?
|
Ultrasonography, Doppler, Duplex | 1 | 2021 | 198 | 0.170 |
Why?
|
Hyperplasia | 2 | 2002 | 1150 | 0.170 |
Why?
|
Imaging, Three-Dimensional | 5 | 2022 | 4052 | 0.170 |
Why?
|
Image Enhancement | 1 | 2010 | 2888 | 0.170 |
Why?
|
Venous Insufficiency | 1 | 2021 | 108 | 0.170 |
Why?
|
Angiography | 4 | 2010 | 1597 | 0.170 |
Why?
|
Odds Ratio | 7 | 2017 | 9652 | 0.170 |
Why?
|
Menopause, Premature | 1 | 2020 | 124 | 0.160 |
Why?
|
Incidence | 9 | 2021 | 21365 | 0.160 |
Why?
|
Cytokines | 2 | 2012 | 7386 | 0.160 |
Why?
|
Hospital Mortality | 9 | 2023 | 5295 | 0.160 |
Why?
|
Mesenteric Vascular Occlusion | 2 | 2011 | 92 | 0.160 |
Why?
|
Brachial Artery | 1 | 2020 | 366 | 0.160 |
Why?
|
Blood Group Antigens | 1 | 2020 | 184 | 0.160 |
Why?
|
Regional Health Planning | 1 | 2019 | 96 | 0.160 |
Why?
|
Multivariate Analysis | 7 | 2017 | 12052 | 0.160 |
Why?
|
Authorship | 1 | 2022 | 284 | 0.160 |
Why?
|
Polytetrafluoroethylene | 1 | 1999 | 245 | 0.150 |
Why?
|
Sexual Harassment | 1 | 2019 | 82 | 0.150 |
Why?
|
Versicans | 1 | 2018 | 40 | 0.150 |
Why?
|
Intraoperative Care | 2 | 2020 | 767 | 0.150 |
Why?
|
Drainage | 1 | 2024 | 1157 | 0.150 |
Why?
|
Physician Executives | 1 | 2019 | 134 | 0.150 |
Why?
|
Aggrecans | 1 | 2018 | 89 | 0.150 |
Why?
|
Ultrasonography, Doppler | 1 | 2020 | 462 | 0.150 |
Why?
|
Professional Practice | 1 | 2020 | 313 | 0.150 |
Why?
|
RNA, Messenger | 11 | 2018 | 12747 | 0.150 |
Why?
|
Surgery Department, Hospital | 1 | 2019 | 176 | 0.150 |
Why?
|
Cone-Beam Computed Tomography | 1 | 2022 | 455 | 0.150 |
Why?
|
Clinical Competence | 3 | 2024 | 4788 | 0.150 |
Why?
|
Specialties, Surgical | 1 | 2022 | 389 | 0.150 |
Why?
|
Down-Regulation | 3 | 2017 | 2916 | 0.140 |
Why?
|
Infectious Disease Transmission, Patient-to-Professional | 1 | 2020 | 250 | 0.140 |
Why?
|
Cultural Competency | 1 | 2020 | 298 | 0.140 |
Why?
|
Muscle, Smooth, Vascular | 4 | 2012 | 1488 | 0.140 |
Why?
|
School Admission Criteria | 1 | 2018 | 107 | 0.140 |
Why?
|
Severity of Illness Index | 9 | 2021 | 15841 | 0.140 |
Why?
|
Hypotension | 1 | 2023 | 879 | 0.140 |
Why?
|
Ultrasonography, Interventional | 3 | 2010 | 1496 | 0.140 |
Why?
|
Catheterization, Peripheral | 1 | 2020 | 343 | 0.140 |
Why?
|
Regional Blood Flow | 2 | 2017 | 1498 | 0.140 |
Why?
|
Nitric Oxide | 3 | 2002 | 2136 | 0.140 |
Why?
|
Cultural Diversity | 1 | 2020 | 369 | 0.140 |
Why?
|
Occupational Exposure | 2 | 2020 | 1814 | 0.140 |
Why?
|
Disease-Free Survival | 2 | 2017 | 6819 | 0.130 |
Why?
|
Collagen Type III | 1 | 2016 | 91 | 0.130 |
Why?
|
Workplace | 2 | 2020 | 864 | 0.130 |
Why?
|
Rats, Sprague-Dawley | 11 | 2012 | 8164 | 0.130 |
Why?
|
Length of Stay | 8 | 2023 | 6417 | 0.130 |
Why?
|
Diagnostic Imaging | 1 | 2010 | 3534 | 0.130 |
Why?
|
Clinical Trials as Topic | 5 | 2020 | 8003 | 0.130 |
Why?
|
Elephants | 1 | 2016 | 41 | 0.130 |
Why?
|
Atherosclerosis | 2 | 2010 | 3406 | 0.130 |
Why?
|
Lipoprotein(a) | 1 | 2020 | 482 | 0.130 |
Why?
|
Terminally Ill | 1 | 2017 | 240 | 0.120 |
Why?
|
Online Systems | 1 | 2016 | 182 | 0.120 |
Why?
|
Specialization | 1 | 2019 | 778 | 0.120 |
Why?
|
Angiography, Digital Subtraction | 3 | 2013 | 335 | 0.120 |
Why?
|
Patient Care | 1 | 2020 | 623 | 0.120 |
Why?
|
Fibrinolytic Agents | 1 | 2024 | 2075 | 0.120 |
Why?
|
Radiography, Interventional | 2 | 2013 | 1122 | 0.120 |
Why?
|
Inflammation | 2 | 2012 | 10759 | 0.120 |
Why?
|
Leg | 2 | 2008 | 1087 | 0.120 |
Why?
|
Healthcare Disparities | 2 | 2021 | 3354 | 0.120 |
Why?
|
Hospitals, Teaching | 1 | 2019 | 1155 | 0.120 |
Why?
|
Anastomosis, Surgical | 3 | 2019 | 982 | 0.110 |
Why?
|
Foreign-Body Migration | 3 | 2013 | 220 | 0.110 |
Why?
|
Women's Health | 2 | 2020 | 2070 | 0.110 |
Why?
|
Nutrition Assessment | 1 | 2017 | 727 | 0.110 |
Why?
|
Aortitis | 1 | 2014 | 76 | 0.110 |
Why?
|
Pulmonary Artery | 1 | 2002 | 1929 | 0.110 |
Why?
|
Operating Room Nursing | 1 | 2013 | 25 | 0.110 |
Why?
|
Image Processing, Computer-Assisted | 1 | 2010 | 8998 | 0.110 |
Why?
|
Mice, Knockout | 6 | 2018 | 14392 | 0.110 |
Why?
|
Acute Disease | 7 | 2021 | 7226 | 0.110 |
Why?
|
Leadership | 2 | 2020 | 1385 | 0.110 |
Why?
|
Proportional Hazards Models | 4 | 2017 | 12474 | 0.110 |
Why?
|
Acute Kidney Injury | 3 | 2023 | 1923 | 0.110 |
Why?
|
Dyslipidemias | 1 | 2020 | 870 | 0.100 |
Why?
|
Vascular System Injuries | 1 | 2016 | 246 | 0.100 |
Why?
|
Peritoneal Cavity | 1 | 2012 | 135 | 0.100 |
Why?
|
Pulmonary Embolism | 2 | 2004 | 2571 | 0.100 |
Why?
|
Collateral Circulation | 1 | 2013 | 293 | 0.100 |
Why?
|
Enzyme Inhibitors | 2 | 2002 | 3702 | 0.100 |
Why?
|
Rats | 12 | 2012 | 23704 | 0.100 |
Why?
|
Vertebral Artery | 1 | 2013 | 184 | 0.100 |
Why?
|
Celiac Artery | 3 | 2013 | 65 | 0.090 |
Why?
|
Receptors, Transforming Growth Factor beta | 1 | 2013 | 302 | 0.090 |
Why?
|
Embolization, Therapeutic | 4 | 2016 | 1419 | 0.090 |
Why?
|
Internship and Residency | 2 | 2024 | 5885 | 0.090 |
Why?
|
Dilatation, Pathologic | 2 | 2010 | 527 | 0.090 |
Why?
|
Mesenteric Artery, Superior | 3 | 2013 | 96 | 0.090 |
Why?
|
Comorbidity | 4 | 2021 | 10516 | 0.090 |
Why?
|
Macrophages, Peritoneal | 1 | 2012 | 238 | 0.090 |
Why?
|
Pre-Eclampsia | 1 | 2020 | 1233 | 0.090 |
Why?
|
Carotid Artery Diseases | 2 | 2010 | 877 | 0.090 |
Why?
|
Chronic Disease | 8 | 2021 | 9319 | 0.090 |
Why?
|
Education, Medical | 2 | 2020 | 1725 | 0.090 |
Why?
|
Faculty, Medical | 1 | 2019 | 1205 | 0.090 |
Why?
|
Periodicals as Topic | 1 | 2022 | 1463 | 0.090 |
Why?
|
STAT5 Transcription Factor | 1 | 2011 | 266 | 0.090 |
Why?
|
DNA Mutational Analysis | 2 | 2016 | 4107 | 0.090 |
Why?
|
Burnout, Professional | 1 | 2019 | 703 | 0.090 |
Why?
|
Spinal Cord | 1 | 2018 | 1807 | 0.090 |
Why?
|
Age Factors | 6 | 2021 | 18384 | 0.090 |
Why?
|
Nitric Oxide Synthase | 2 | 2004 | 908 | 0.090 |
Why?
|
Nursing Staff, Hospital | 1 | 2013 | 348 | 0.090 |
Why?
|
Analysis of Variance | 2 | 2010 | 6223 | 0.080 |
Why?
|
Phosphorylation | 2 | 2011 | 8300 | 0.080 |
Why?
|
Politics | 1 | 2016 | 814 | 0.080 |
Why?
|
Geriatric Assessment | 1 | 2017 | 1409 | 0.080 |
Why?
|
Health Status Disparities | 1 | 2021 | 1847 | 0.080 |
Why?
|
Medical Staff, Hospital | 1 | 2013 | 601 | 0.080 |
Why?
|
Animals | 19 | 2018 | 168079 | 0.080 |
Why?
|
Life Tables | 3 | 2010 | 364 | 0.080 |
Why?
|
Wound Healing | 1 | 2020 | 2800 | 0.080 |
Why?
|
Medical Informatics | 1 | 2016 | 733 | 0.080 |
Why?
|
Vasoconstrictor Agents | 1 | 2012 | 655 | 0.080 |
Why?
|
Interleukin-10 | 2 | 2012 | 1176 | 0.080 |
Why?
|
Registries | 6 | 2021 | 8247 | 0.080 |
Why?
|
Vasculitis | 1 | 2012 | 522 | 0.070 |
Why?
|
Michigan | 2 | 2006 | 339 | 0.070 |
Why?
|
Medicine | 1 | 2016 | 942 | 0.070 |
Why?
|
Attitude of Health Personnel | 2 | 2019 | 3885 | 0.070 |
Why?
|
Radiation Dosage | 2 | 2013 | 1962 | 0.070 |
Why?
|
Patient Transfer | 1 | 2014 | 794 | 0.070 |
Why?
|
Mesenteric Artery, Inferior | 2 | 2008 | 15 | 0.070 |
Why?
|
STAT3 Transcription Factor | 1 | 2011 | 872 | 0.070 |
Why?
|
Th1 Cells | 1 | 2012 | 1042 | 0.070 |
Why?
|
Operating Rooms | 1 | 2013 | 790 | 0.070 |
Why?
|
Health Personnel | 1 | 2020 | 3337 | 0.070 |
Why?
|
Th2 Cells | 1 | 2012 | 1071 | 0.070 |
Why?
|
Pilot Projects | 3 | 2024 | 8642 | 0.070 |
Why?
|
Patient Discharge | 1 | 2019 | 3441 | 0.070 |
Why?
|
Kidney Diseases | 1 | 2017 | 2092 | 0.070 |
Why?
|
Hospitals, Military | 1 | 2006 | 62 | 0.070 |
Why?
|
Arteriovenous Shunt, Surgical | 1 | 2009 | 290 | 0.070 |
Why?
|
Disease Models, Animal | 5 | 2018 | 18220 | 0.070 |
Why?
|
Hemodynamics | 2 | 2017 | 4165 | 0.070 |
Why?
|
Nitroso Compounds | 1 | 2006 | 71 | 0.060 |
Why?
|
Tissue Scaffolds | 1 | 2012 | 932 | 0.060 |
Why?
|
Prognosis | 5 | 2021 | 29687 | 0.060 |
Why?
|
Syndrome | 2 | 2014 | 3271 | 0.060 |
Why?
|
Tissue Inhibitor of Metalloproteinase-1 | 2 | 2005 | 151 | 0.060 |
Why?
|
Nitric Oxide Donors | 1 | 2006 | 126 | 0.060 |
Why?
|
Adult | 18 | 2024 | 221119 | 0.060 |
Why?
|
Pulmonary Disease, Chronic Obstructive | 3 | 2012 | 3201 | 0.060 |
Why?
|
Genetic Predisposition to Disease | 5 | 2016 | 17897 | 0.060 |
Why?
|
Phenotype | 4 | 2016 | 16575 | 0.060 |
Why?
|
L-Selectin | 1 | 2005 | 212 | 0.060 |
Why?
|
Carotid Artery, External | 1 | 2004 | 37 | 0.060 |
Why?
|
Stainless Steel | 1 | 2024 | 79 | 0.060 |
Why?
|
Heart Defects, Congenital | 1 | 2021 | 4673 | 0.060 |
Why?
|
Catalase | 1 | 2005 | 217 | 0.060 |
Why?
|
Coronary Disease | 1 | 2019 | 5921 | 0.060 |
Why?
|
Selective Estrogen Receptor Modulators | 1 | 2005 | 131 | 0.060 |
Why?
|
Learning Curve | 2 | 2017 | 230 | 0.060 |
Why?
|
Communication | 1 | 2018 | 3872 | 0.060 |
Why?
|
Perfusion | 2 | 2005 | 1390 | 0.060 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 3 | 2006 | 4567 | 0.060 |
Why?
|
Hospitals, University | 1 | 2006 | 565 | 0.060 |
Why?
|
Algorithms | 2 | 2024 | 14025 | 0.060 |
Why?
|
Decision Making | 1 | 2017 | 3931 | 0.050 |
Why?
|
Emergencies | 3 | 2016 | 1217 | 0.050 |
Why?
|
Thrombophlebitis | 2 | 2001 | 289 | 0.050 |
Why?
|
Hypolipidemic Agents | 1 | 2008 | 609 | 0.050 |
Why?
|
Hemorrhage | 2 | 2014 | 3422 | 0.050 |
Why?
|
Matrix Metalloproteinase 3 | 1 | 2004 | 138 | 0.050 |
Why?
|
Renal Insufficiency | 1 | 2009 | 808 | 0.050 |
Why?
|
Recovery of Function | 1 | 2013 | 2981 | 0.050 |
Why?
|
Hypertension | 1 | 2023 | 8536 | 0.050 |
Why?
|
Follow-Up Studies | 8 | 2021 | 39126 | 0.050 |
Why?
|
Anesthesiology | 1 | 2013 | 1122 | 0.050 |
Why?
|
Cells, Cultured | 5 | 2012 | 18926 | 0.050 |
Why?
|
Popliteal Vein | 1 | 2002 | 43 | 0.050 |
Why?
|
Stress, Psychological | 1 | 2018 | 4487 | 0.050 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2010 | 3803 | 0.050 |
Why?
|
Tissue Engineering | 1 | 2012 | 1865 | 0.050 |
Why?
|
Chemotaxis, Leukocyte | 1 | 2005 | 660 | 0.050 |
Why?
|
Saphenous Vein | 2 | 2013 | 516 | 0.050 |
Why?
|
Platelet Function Tests | 1 | 2024 | 271 | 0.050 |
Why?
|
Recurrence | 3 | 2011 | 8457 | 0.050 |
Why?
|
Gelatinases | 1 | 2002 | 88 | 0.050 |
Why?
|
Neutrophil Infiltration | 1 | 2005 | 390 | 0.050 |
Why?
|
Transcription Factor AP-1 | 1 | 2004 | 318 | 0.050 |
Why?
|
Evidence-Based Medicine | 3 | 2010 | 3691 | 0.050 |
Why?
|
Propensity Score | 2 | 2020 | 1916 | 0.050 |
Why?
|
Femoral Vein | 1 | 2002 | 153 | 0.050 |
Why?
|
Enzyme Precursors | 1 | 2002 | 167 | 0.050 |
Why?
|
Veins | 1 | 2006 | 767 | 0.050 |
Why?
|
Nitrites | 1 | 2002 | 156 | 0.050 |
Why?
|
Culture Techniques | 1 | 2002 | 531 | 0.050 |
Why?
|
Anesthesia, Local | 1 | 2024 | 277 | 0.050 |
Why?
|
Survival Rate | 6 | 2014 | 12728 | 0.050 |
Why?
|
Logistic Models | 4 | 2021 | 13249 | 0.050 |
Why?
|
Arrhythmias, Cardiac | 1 | 2011 | 2247 | 0.050 |
Why?
|
Trauma Centers | 1 | 2006 | 938 | 0.040 |
Why?
|
E-Selectin | 1 | 2003 | 577 | 0.040 |
Why?
|
Hospitalization | 1 | 2020 | 10707 | 0.040 |
Why?
|
P-Selectin | 1 | 2003 | 599 | 0.040 |
Why?
|
Tamoxifen | 1 | 2005 | 965 | 0.040 |
Why?
|
Mutation | 2 | 2016 | 30002 | 0.040 |
Why?
|
Fibrin | 1 | 2003 | 507 | 0.040 |
Why?
|
Myocardial Infarction | 4 | 2019 | 11476 | 0.040 |
Why?
|
Mice | 5 | 2012 | 81326 | 0.040 |
Why?
|
Molecular Weight | 1 | 2002 | 2171 | 0.040 |
Why?
|
Sclerotherapy | 1 | 2021 | 182 | 0.040 |
Why?
|
Coronary Artery Disease | 1 | 2019 | 6505 | 0.040 |
Why?
|
Platelet Aggregation | 1 | 2022 | 771 | 0.040 |
Why?
|
Myocytes, Smooth Muscle | 1 | 2004 | 698 | 0.040 |
Why?
|
Secondary Prevention | 1 | 2006 | 1472 | 0.040 |
Why?
|
Punctures | 1 | 2020 | 366 | 0.040 |
Why?
|
Urinary Catheterization | 1 | 2020 | 193 | 0.040 |
Why?
|
Nitric Oxide Synthase Type III | 1 | 2002 | 705 | 0.040 |
Why?
|
Career Mobility | 1 | 2020 | 259 | 0.040 |
Why?
|
Reference Values | 1 | 2005 | 4921 | 0.040 |
Why?
|
Chemokines | 1 | 2002 | 956 | 0.040 |
Why?
|
Patient Care Team | 1 | 2009 | 2515 | 0.040 |
Why?
|
Urodynamics | 1 | 2020 | 346 | 0.040 |
Why?
|
Kinetics | 1 | 2005 | 6312 | 0.040 |
Why?
|
Arteries | 1 | 2023 | 1121 | 0.040 |
Why?
|
Paraplegia | 1 | 2018 | 161 | 0.040 |
Why?
|
Tunica Media | 1 | 2018 | 110 | 0.040 |
Why?
|
Rehabilitation Centers | 1 | 2019 | 246 | 0.040 |
Why?
|
Upper Extremity | 1 | 2022 | 658 | 0.040 |
Why?
|
Ligation | 2 | 2013 | 446 | 0.040 |
Why?
|
Boston | 2 | 2020 | 9327 | 0.040 |
Why?
|
Kidney Failure, Chronic | 1 | 2009 | 2478 | 0.030 |
Why?
|
Organizational Culture | 1 | 2020 | 509 | 0.030 |
Why?
|
Cohort Studies | 4 | 2023 | 41496 | 0.030 |
Why?
|
Advisory Committees | 1 | 2020 | 788 | 0.030 |
Why?
|
Polymerase Chain Reaction | 1 | 2005 | 6067 | 0.030 |
Why?
|
Substance Withdrawal Syndrome | 1 | 2001 | 624 | 0.030 |
Why?
|
Survival Analysis | 2 | 1999 | 10088 | 0.030 |
Why?
|
Disease Progression | 3 | 2022 | 13511 | 0.030 |
Why?
|
Constriction, Pathologic | 2 | 2010 | 1097 | 0.030 |
Why?
|
Neutrophils | 2 | 2005 | 3763 | 0.030 |
Why?
|
NF-kappa B | 1 | 2004 | 2475 | 0.030 |
Why?
|
Skilled Nursing Facilities | 1 | 2019 | 400 | 0.030 |
Why?
|
Prevalence | 2 | 2024 | 15721 | 0.030 |
Why?
|
Cardiovascular Diseases | 1 | 2020 | 15520 | 0.030 |
Why?
|
Clinical Protocols | 1 | 2020 | 1436 | 0.030 |
Why?
|
Canada | 1 | 2020 | 2125 | 0.030 |
Why?
|
Regional Medical Programs | 1 | 2014 | 66 | 0.030 |
Why?
|
Pedigree | 2 | 2013 | 4537 | 0.030 |
Why?
|
Warfarin | 1 | 2002 | 1482 | 0.030 |
Why?
|
Sweden | 1 | 2017 | 1379 | 0.030 |
Why?
|
Drug Therapy, Combination | 1 | 2024 | 6304 | 0.030 |
Why?
|
Africa | 1 | 2016 | 714 | 0.030 |
Why?
|
Dose-Response Relationship, Drug | 2 | 2006 | 10756 | 0.030 |
Why?
|
Thoracic Surgery | 1 | 2020 | 722 | 0.030 |
Why?
|
Renal Dialysis | 2 | 2019 | 1796 | 0.030 |
Why?
|
Postpartum Period | 1 | 2020 | 1178 | 0.030 |
Why?
|
Antihypertensive Agents | 1 | 2023 | 2019 | 0.030 |
Why?
|
Consensus | 1 | 2023 | 3134 | 0.030 |
Why?
|
Age Distribution | 1 | 2019 | 2871 | 0.030 |
Why?
|
Family Characteristics | 1 | 2018 | 992 | 0.030 |
Why?
|
Protective Clothing | 1 | 2013 | 103 | 0.030 |
Why?
|
Heredity | 1 | 2013 | 148 | 0.030 |
Why?
|
Health Care Surveys | 1 | 2020 | 2425 | 0.030 |
Why?
|
Aneurysm, Ruptured | 1 | 1998 | 464 | 0.030 |
Why?
|
Radiation Monitoring | 1 | 2013 | 103 | 0.030 |
Why?
|
New Zealand | 1 | 2013 | 358 | 0.030 |
Why?
|
Aspirin | 1 | 2024 | 3129 | 0.030 |
Why?
|
Chile | 1 | 2013 | 256 | 0.030 |
Why?
|
Medicare | 2 | 2020 | 6773 | 0.030 |
Why?
|
Mitochondria | 1 | 2005 | 3620 | 0.020 |
Why?
|
Multicenter Studies as Topic | 1 | 2017 | 1702 | 0.020 |
Why?
|
Atrial Fibrillation | 1 | 2011 | 5114 | 0.020 |
Why?
|
Blood Platelets | 1 | 2022 | 2477 | 0.020 |
Why?
|
Porosity | 1 | 2012 | 348 | 0.020 |
Why?
|
Intestines | 1 | 2021 | 1908 | 0.020 |
Why?
|
Publishing | 1 | 2019 | 832 | 0.020 |
Why?
|
Neoplasms | 1 | 2021 | 22140 | 0.020 |
Why?
|
Tensile Strength | 1 | 2012 | 330 | 0.020 |
Why?
|
Intraoperative Complications | 1 | 2018 | 1164 | 0.020 |
Why?
|
Inpatients | 1 | 2023 | 2545 | 0.020 |
Why?
|
Massachusetts | 1 | 2024 | 8837 | 0.020 |
Why?
|
Postmenopause | 1 | 2020 | 2514 | 0.020 |
Why?
|
Polyesters | 1 | 2012 | 371 | 0.020 |
Why?
|
South Africa | 1 | 2016 | 1843 | 0.020 |
Why?
|
Linear Models | 2 | 2011 | 5869 | 0.020 |
Why?
|
Embolectomy | 1 | 2011 | 130 | 0.020 |
Why?
|
Pregnancy | 2 | 2023 | 29893 | 0.020 |
Why?
|
Intraoperative Period | 1 | 2011 | 510 | 0.020 |
Why?
|
Pregnancy Outcome | 1 | 2020 | 2923 | 0.020 |
Why?
|
Radiation Protection | 1 | 2013 | 426 | 0.020 |
Why?
|
Apoptosis | 1 | 2005 | 9477 | 0.020 |
Why?
|
Quality Indicators, Health Care | 1 | 2019 | 1789 | 0.020 |
Why?
|
Contrast Media | 2 | 2013 | 5311 | 0.020 |
Why?
|
Respiratory Insufficiency | 2 | 2011 | 1232 | 0.020 |
Why?
|
Combined Modality Therapy | 1 | 2020 | 8519 | 0.020 |
Why?
|
Prosthesis-Related Infections | 1 | 2013 | 488 | 0.020 |
Why?
|
Review Literature as Topic | 1 | 2010 | 348 | 0.020 |
Why?
|
Equipment Design | 1 | 2016 | 3510 | 0.020 |
Why?
|
Quality Improvement | 1 | 2023 | 3808 | 0.020 |
Why?
|
Benchmarking | 1 | 2014 | 1045 | 0.020 |
Why?
|
Tibial Arteries | 1 | 2008 | 60 | 0.020 |
Why?
|
Internet | 1 | 2020 | 3096 | 0.020 |
Why?
|
Mice, Inbred C57BL | 1 | 2006 | 22127 | 0.020 |
Why?
|
Practice Guidelines as Topic | 2 | 2020 | 7400 | 0.020 |
Why?
|
Embolism | 1 | 2011 | 399 | 0.020 |
Why?
|
Sensitivity and Specificity | 1 | 2002 | 14675 | 0.020 |
Why?
|
Catheters, Indwelling | 1 | 2009 | 426 | 0.020 |
Why?
|
Databases as Topic | 1 | 2009 | 473 | 0.020 |
Why?
|
Occupational Health | 1 | 2013 | 807 | 0.020 |
Why?
|
Immunohistochemistry | 3 | 2005 | 11067 | 0.020 |
Why?
|
Afghanistan | 1 | 2006 | 77 | 0.020 |
Why?
|
Iraq | 1 | 2006 | 92 | 0.020 |
Why?
|
Catheterization | 2 | 2004 | 1428 | 0.020 |
Why?
|
Europe | 1 | 2013 | 3423 | 0.020 |
Why?
|
Vietnam Conflict | 1 | 2006 | 101 | 0.020 |
Why?
|
Blotting, Western | 2 | 2005 | 5032 | 0.020 |
Why?
|
Radiation Injuries | 1 | 2013 | 1191 | 0.020 |
Why?
|
Health Status | 1 | 2019 | 4077 | 0.020 |
Why?
|
Thrombectomy | 1 | 2011 | 703 | 0.020 |
Why?
|
Troponin T | 1 | 2011 | 780 | 0.020 |
Why?
|
Amitrole | 1 | 2005 | 8 | 0.020 |
Why?
|
Caspase 9 | 1 | 2005 | 184 | 0.020 |
Why?
|
Phlebography | 1 | 2006 | 326 | 0.020 |
Why?
|
Extracellular Matrix | 1 | 2012 | 1720 | 0.020 |
Why?
|
Technology Transfer | 1 | 2004 | 42 | 0.010 |
Why?
|
Catheterization, Central Venous | 1 | 2009 | 526 | 0.010 |
Why?
|
Postoperative Care | 1 | 2010 | 1468 | 0.010 |
Why?
|
Longitudinal Studies | 1 | 2020 | 14610 | 0.010 |
Why?
|
Signal Transduction | 1 | 2007 | 23416 | 0.010 |
Why?
|
Tissue Inhibitor of Metalloproteinases | 1 | 2004 | 97 | 0.010 |
Why?
|
Observer Variation | 1 | 2010 | 2610 | 0.010 |
Why?
|
Anxiety | 1 | 2018 | 4569 | 0.010 |
Why?
|
Caspase 3 | 1 | 2005 | 730 | 0.010 |
Why?
|
Guanidines | 1 | 2004 | 194 | 0.010 |
Why?
|
Digestive System Surgical Procedures | 1 | 2008 | 571 | 0.010 |
Why?
|
Health Care Sector | 1 | 2004 | 195 | 0.010 |
Why?
|
Caspases | 1 | 2005 | 878 | 0.010 |
Why?
|
Nitric Oxide Synthase Type II | 1 | 2004 | 517 | 0.010 |
Why?
|
Biomedical Technology | 1 | 2004 | 210 | 0.010 |
Why?
|
Microscopy, Electron | 1 | 2005 | 2561 | 0.010 |
Why?
|
Radiography | 2 | 2004 | 6974 | 0.010 |
Why?
|
Tomography, Spiral Computed | 1 | 2003 | 273 | 0.010 |
Why?
|
Gene Expression Profiling | 1 | 2018 | 9416 | 0.010 |
Why?
|
Child | 3 | 2023 | 80152 | 0.010 |
Why?
|
Splanchnic Circulation | 1 | 2002 | 119 | 0.010 |
Why?
|
Case-Control Studies | 2 | 2012 | 22174 | 0.010 |
Why?
|
Adolescent | 3 | 2023 | 88298 | 0.010 |
Why?
|
Diabetes Mellitus | 1 | 2020 | 5842 | 0.010 |
Why?
|
Staining and Labeling | 1 | 2005 | 1080 | 0.010 |
Why?
|
Cell Count | 1 | 2005 | 1831 | 0.010 |
Why?
|
Young Adult | 2 | 2023 | 59221 | 0.010 |
Why?
|
Calcinosis | 1 | 2010 | 1477 | 0.010 |
Why?
|
Lymphocyte Count | 1 | 2003 | 781 | 0.010 |
Why?
|
Cytosol | 1 | 2004 | 883 | 0.010 |
Why?
|
Physicians | 1 | 2018 | 4584 | 0.010 |
Why?
|
Radionuclide Imaging | 1 | 2004 | 1989 | 0.010 |
Why?
|
Enzyme Activation | 1 | 2005 | 3577 | 0.010 |
Why?
|
Protein Precursors | 1 | 2004 | 1132 | 0.010 |
Why?
|
Electrophoresis, Polyacrylamide Gel | 1 | 2001 | 1728 | 0.010 |
Why?
|
Tracheostomy | 1 | 2003 | 426 | 0.010 |
Why?
|
Fatal Outcome | 1 | 2003 | 1838 | 0.010 |
Why?
|
Carotid Artery Injuries | 1 | 1999 | 96 | 0.010 |
Why?
|
Leukocyte Count | 1 | 2003 | 1597 | 0.010 |
Why?
|
Health Knowledge, Attitudes, Practice | 1 | 2013 | 4014 | 0.010 |
Why?
|
History, 20th Century | 1 | 2006 | 2765 | 0.010 |
Why?
|
Cross-Sectional Studies | 1 | 2019 | 26071 | 0.010 |
Why?
|
Microscopy | 1 | 2003 | 904 | 0.010 |
Why?
|
Fascia | 1 | 1998 | 140 | 0.010 |
Why?
|
Thigh | 1 | 1998 | 239 | 0.010 |
Why?
|
Compartment Syndromes | 1 | 1998 | 159 | 0.010 |
Why?
|
Up-Regulation | 1 | 2005 | 4111 | 0.010 |
Why?
|
Ethanol | 1 | 2001 | 1322 | 0.010 |
Why?
|
Child, Preschool | 2 | 2009 | 42224 | 0.010 |
Why?
|
Monocytes | 1 | 2003 | 2570 | 0.010 |
Why?
|
Wounds and Injuries | 1 | 2006 | 2493 | 0.010 |
Why?
|
Gene Expression | 1 | 2005 | 7571 | 0.010 |
Why?
|
Radiotherapy Dosage | 1 | 1999 | 2897 | 0.010 |
Why?
|
Reproducibility of Results | 1 | 2010 | 20119 | 0.010 |
Why?
|
Ultrasonography | 1 | 2004 | 5969 | 0.010 |
Why?
|
Macrophages | 1 | 2005 | 5753 | 0.010 |
Why?
|
HIV Infections | 1 | 2016 | 17347 | 0.010 |
Why?
|
Endothelium, Vascular | 1 | 2002 | 4420 | 0.010 |
Why?
|
Anemia | 1 | 1998 | 1504 | 0.000 |
Why?
|
Gene Expression Regulation | 1 | 2005 | 11856 | 0.000 |
Why?
|